Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
4/24/2017 Routine Reaction to DPLD (AKA ILD) No longer living in the Shadows: ILD hits primetime Yolanda Mageto MD, MPH Professor of Medicine Director of Interstitial Lung Disease Center for Advanced Heart and Lung Disease Baylor Scott and White The Diagnosis of DPLD is Difficult! • Diverse group of illnesses of over 150 disorders involving the distal pulmonary parenchyma Disclosures: None • Similar in presentation, physiology, radiology and sometimes pathology • Successful management of these patients depends on accurate diagnosis based on history and interpretation of data • Accurate diagnosis allows • Provision of accurate prognostic information • Development of a management strategy Learning Objectives 1. Highlight the rationale for an accurate diagnostic approach patients with suspected interstitial lung disease Diffuse Parenchymal Lung Disease (DPLD) Idiopathic interstitial pneumonias DPLD of known cause, eg, drugs or association, eg, collagen vascular disease Idiopathic pulmonary fibrosis 2. Apply a sequential algorithmic approach to diagnosis in patients with suspected interstitial lung disease, while highlighting complexity involved in diagnosis Classification of DPLD OR of Known Cause? Granulomatous DPLD, eg, sarcoidosis Other forms of DPLD, eg, LAM, HX, etc IIP other than idiopathic pulmonary fibrosis Desquamative interstitial pneumonia Respiratory bronchiolitis interstitial lung disease Acute interstitial pneumonia Cryptogenic organizing pneumonia Nonspecific interstitial pneumonia (provisional) Lymphocytic interstitial pneumonia Pleuroparenchymal fibroelastosis Travis WD, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-748. 1 4/24/2017 Diagnostic Tools Recommended Autoantibody Screening Clinical Assessment • Comprehensive medical history ( focusing on social, occupational, environmental, drug, and family) • Time course • Pulmonary function testing • Physical exam – pulmonary • Serologic testing Radiological Assessment • Chest x-ray • HRCT Surgical Assessment • Bronchoscopy or surgical lung biopsy as indicated Diagnostic Algorithm for IPF Case Study (ies): Patient presents with suspected ILD Detailed history Physical exam PFT YES Positive •58 year old female with cough and dyspnea Identifiable cause of ILD Serologic testing to exclude CTD Definite UIP HRCT IPF Not IPF Raghu G, et al. Am J Respir Crit Care Med. 2011;183:788-824 Known Causes of ILD: • Drugs – eg, Amiodarone, bleomycin, nitrofurantoin, cocaine, – www.pneumotox.com • Radiation ‒ External beam radiation therapy to thorax • Connective Tissue Diseases – Rheumatoid arthritis – Systemic sclerosis (scleroderma) – Idiopathic inflammatory myopathies – Vasculitis – Primary Sjogren’s – Bechet’s syndrome • Occupational/Environmental – Inorganic antigens (Pneumoconioses) • Asbestosis • Coal worker’s pneumoconiosis • Silicosis – Organic antigens (Hypersensitivity Pneumonitis) • Birds • Mold • Farm antigens 58 year old female with cough and dyspnea • Presenting symptoms • Very Active female bikes several miles weekly no significant past medical history • Cough dry non productive x 3 months initially attributed to allergy, treated with inhaler no improvement, progressively worse • Dry non productive • Exertional dyspnea progressive over the last year • Bibasilar crackles on exam • Further imaging. 2 4/24/2017 Case Study: 58 year old female (cont’d) Case Study: 58 year old female (cont’d) • Lifelong non smoker – no second hand smoke • No family history of collagen vascular disease or pulmonary issues • No recent travels • Physical exam: • Occasional swelling in her joints, • Crackles on exam ¼ way up otherwise negative exam • No history or Raynaud's, rashes or apthous ulcers. Case Study: 58 year old female (cont’d) Case Study: 58 year old female (cont’d) • PFT’s • Clinical course: • • • • FVC 3.26 (86%) FEV1 2.57 (84%) FEV1/FVC 0.79 DLCO 60% • Serologic testing • ANA 1:60 • RF 40 • All other testing negative Case Study: 58 year old female (cont’d) • Initially diagnosed with IPF • • • • • However further history taking revealed patient was a pigeon breeder in her spare time Diagnosis: chronic hypersensitivity pneumonitis. Treated with steroids Birds removed Symptoms improved and PFT’S remained stable. Case Study: 58 year old female (cont’d) • SAME PRESENTATION Different History • Elevated SCL -70 or CCP antibodies or aldolase – likely CT ILD • Medications – amiodarone, Methotrexate, Nitrofurantoin – likely medication induced fibrosis • NO additional history of findings then likely IPF • IF UNSURE GET A BIOPSY – to be read by a lung pathologist. 3 4/24/2017 Care of the ILD patient Disease Based Management Pharmacologic Therapy Non Pharmacologic Therapy Education and Self Management Symptom Centered Management Knowledge Cough Dyspnea Values and Preferences Co-Morbidities and Complications Preventative Care Advanced Care Planning Fatigue and Deconditioning Depression and Anxiety Adapted from Lee, Joyce; McLaughlin, Sally; Collard, Harold; Current Opinion in Pulmonary Medicine. 17(5):348-354, September 2011. A few take home thoughts ….. • IIP is an evolving arena – keep an open mind • Be consistent in your approach to diagnosis • PFT’s can be normal • Patients often have comorbidities don’t get tunnel vision • If the clinical radiographic picture does not fit acquire TISSUE! • All Lower lobe infiltrates are not ‘double pneumonia’ • Make the investment up front -Good history taking is Key !! 22 Tunnel Vision: Concomitant disease and comorbidities Summary: Concomitant Disease/Comorbidities • Avoid Tunnel vision • Recognize a change in symptoms may not be due to IPF or ILD • Consider • • • • • • OSA Cancer CAD GERD PAH Emphysema (COPD exacerbation) 4